Candel Therapeutics (CADL) Revenue: 2020-2024
Historic Revenue for Candel Therapeutics (CADL) over the last 5 years, with Dec 2024 value amounting to $2.1 million.
- Candel Therapeutics' Revenue rose 14470.97% to $4.5 million in Q4 2023 from the same period last year, while for Dec 2023 it was $2.6 million, marking a year-over-year increase of 1992.74%. This contributed to the annual value of $2.1 million for FY2024, which is 19.46% down from last year.
- As of FY2024, Candel Therapeutics' Revenue stood at $2.1 million, which was down 19.46% from $2.6 million recorded in FY2023.
- Over the past 5 years, Candel Therapeutics' Revenue peaked at $2.6 million during FY2023, and registered a low of $125,000 during FY2020.
- Its 3-year average for Revenue is $1.6 million, with a median of $2.1 million in 2024.
- Per our database at Business Quant, Candel Therapeutics' Revenue soared by 1,976.00% in 2023 and then decreased by 19.46% in 2024.
- Candel Therapeutics' Revenue (Yearly) stood at $125,000 in 2020, then remained steady at $125,000 in 2021, then remained steady at $125,000 in 2022, then spiked by 1,976.00% to $2.6 million in 2023, then decreased by 19.46% to $2.1 million in 2024.